J. Dalmau, E. Lancaster, and E. Martinez-hernandez, Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis, The Lancet Neurology, vol.10, issue.1, pp.63-74, 2011.
DOI : 10.1016/S1474-4422(10)70253-2

L. Misakova, D. Rossi, P. Bouchet, and D. , Disrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitis, Brain, vol.135, pp.1606-1621, 2012.

F. Blanc, H. Zéphir, and C. Lebrun, Cognitive Functions in Neuromyelitis Optica, Archives of Neurology, vol.65, issue.1, pp.84-88, 2008.
DOI : 10.1001/archneurol.2007.16

R. Taylor, W. Mason, and K. Kong, Conclusion:, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, vol.11, issue.04, pp.317-320, 1999.
DOI : 10.1093/brain/91.3.481

M. Kruer, T. Koch, and D. Bourdette, NMDA RECEPTOR ENCEPHALITIS MIMICKING SERONEGATIVE NEUROMYELITIS OPTICA, Neurology, vol.74, issue.18, pp.1473-1475, 2010.
DOI : 10.1212/WNL.0b013e3181dc1a7f

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2872802

A. Lekoubou, A. Viaccoz, and A. Didelot, -methyl-D-aspartate receptor encephalitis with acute disseminated encephalomyelitis-like MRI features, European Journal of Neurology, vol.74, issue.2, pp.16-17, 2012.
DOI : 10.1111/j.1468-1331.2011.03617.x

J. Dalmau, E. Tüzün, and H. Wu, -methyl-D-aspartate receptor encephalitis associated with ovarian teratoma, Annals of Neurology, vol.127, issue.1, pp.25-36, 2007.
DOI : 10.1002/ana.21050

URL : https://hal.archives-ouvertes.fr/hal-00408663

J. Dalmau, A. Gleichman, and E. Hughes, Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies, The Lancet Neurology, vol.7, issue.12, pp.1091-1098, 2008.
DOI : 10.1016/S1474-4422(08)70224-2

P. Paoletti, C. Bellone, and Q. Zhou, NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease, Nature Reviews Neuroscience, vol.135, issue.6, pp.383-400, 2013.
DOI : 10.1038/nrn3504

S. Pittock, B. Weinshenker, and C. Lucchinetti, Neuromyelitis Optica Brain Lesions Localized at Sites of High Aquaporin 4 Expression, Archives of Neurology, vol.63, issue.7, pp.964-968, 2006.
DOI : 10.1001/archneur.63.7.964

P. Banker, S. Sonni, and I. Kister, Pencil-thin ependymal enhancement in neuromyelitis optica spectrum disorders, Multiple Sclerosis Journal, vol.30, issue.3, pp.1050-1053, 2012.
DOI : 10.1212/WNL.0b013e3181f8832e

F. Costello, S. Coupland, and W. Hodge, Quantifying axonal loss after optic neuritis with optical coherence tomography, Annals of Neurology, vol.13, issue.6, pp.963-969, 2006.
DOI : 10.1002/ana.20851

N. Ishikawa, G. Tajima, and S. Hyodo, Detection of Autoantibodies against NMDA-Type Glutamate Receptor in a Patient with Recurrent Optic Neuritis and Transient Cerebral Lesions, Neuropediatrics, vol.38, issue.5, pp.257-260, 2007.
DOI : 10.1055/s-2007-1004521

E. Frechette, L. Zhou, and S. Galetta, Prolonged Follow-up and CSF Antibody Titers in a Patient With Anti-NMDA Receptor Encephalitis, Neurology, vol.76, issue.Issue 7, Supplement 2, pp.64-66, 2011.
DOI : 10.1212/WNL.0b013e31820c34de

H. Pruss, C. Finke, M. Höltje, J. Hofmann, C. Klingbeil et al., -aspartate receptor antibodies in herpes simplex encephalitis, Annals of Neurology, vol.10, issue.6, pp.902-911, 2012.
DOI : 10.1002/ana.23689

URL : https://hal.archives-ouvertes.fr/inserm-00920557

T. Gono, Y. Kawaguchi, H. Kaneko, K. Nishimura, M. Hanaoka et al., Anti-NR2A antibody as a predictor for neuropsychiatric systemic lupus erythematosus, Rheumatology, vol.50, issue.9, pp.1578-1585, 2011.
DOI : 10.1093/rheumatology/keq408

M. Zoccarato, M. Saddi, G. Serra, M. Pelizza, I. Rosellini et al., Aquaporin-4 antibody neuromyelitis optica following anti-NMDA receptor encephalitis, Journal of Neurology, vol.15, issue.12, pp.3185-3187, 2013.
DOI : 10.1007/s00415-013-7182-x